2 results
Approved WMOCompleted
Primary Objectives:Safety Run-in PartTo establish a safe and tolerable dose of azacitidine to be used in the randomized part of thestudy.Randomized PartTo evaluate the effect of azacitidine treatment in AML subjects at molecular relapse after…
Approved WMOCompleted
The objective of this study is to observe the anatomical and functional outcomes of ocriplasmin over a 6-month follow-up period.